tiprankstipranks

Jeffrey Keyser Insider Profile

4 Followers
Jeffrey Keyser, Director at Lantern Pharma, holds 94.30K shares in Lantern Pharma (Ticker: LTRN), holds 0.00 shares in ZS Pharma (Ticker: ZSPH). Most recently, Jeffrey Keyser Bought ― shares of Lantern Pharma on May 14, 2026 for an estimated value of $100.00K.
tipranks
Jeffrey Keyser

Jeffrey Keyser
Lantern Pharma (LTRN)
Director

Ranked #73,230 out of 108,921 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

-14.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$174K
100.00%
A breakdown of Jeffrey Keyser's holdings

Insider Roles

Lantern Pharma
(LTRN)
Director
Roles that Jeffrey Keyser holds in companies

Most Profitable Insider Trade

Stock:
Lantern Pharma
(LTRN)
Rating:Informative Buy
Date:Jun 15, 2020 - Jun 15, 2021
Return:+2.60%
The most profitable trade made by Jeffrey Keyser

Jeffrey Keyser's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Lantern Pharma
May 14, 2026
Director
Informative Buy
100.00K
$173.52K
ZSPH
ZS Pharma
Dec 21, 2015
Uninformative Sell
1.11M
$0.00
List of latest transactions for each holding click on a transaction to see Jeffrey Keyser's performance on stock

Jeffrey Keyser insider profile FAQ

What is the percentage of profitable transactions made by Jeffrey Keyser?
The percentage of profitable transactions made by Jeffrey Keyser is 33%.
    What is the average return per transaction made by Jeffrey Keyser?
    The average return per transaction made by Jeffrey Keyser is -14.60%.
      What stocks does Jeffrey Keyser hold?
      Jeffrey Keyser holds: LTRN, ZSPH stocks.
        What was Jeffrey Keyser’s latest transaction?
        Jeffrey Keyser latest transaction was an Informative Buy of $100.00K.
          What was Jeffrey Keyser's most profitable transaction?
          Jeffrey Keyser’s most profitable transaction was an Informative Buy of LTRN stock on June 15, 2020. The return on the trade was 2.60%.
            What is Jeffrey Keyser's role in Lantern Pharma?
            Jeffrey Keyser's role in Lantern Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.